Quantbot Technologies LP boosted its stake in Acuren Corp (NYSEAMERICAN:TIC – Free Report) by 1,371.3% in the third quarter, HoldingsChannel reports. The firm owned 283,718 shares of the company’s stock after acquiring an additional 264,435 shares during the period. Quantbot Technologies LP’s holdings in Acuren were worth $3,776,000 as of its most recent filing with the Securities and Exchange Commission.
A number of other hedge funds have also added to or reduced their stakes in TIC. Vanguard Group Inc. lifted its holdings in shares of Acuren by 100.8% during the 3rd quarter. Vanguard Group Inc. now owns 8,528,717 shares of the company’s stock valued at $113,517,000 after buying an additional 4,280,384 shares during the period. Swedbank AB purchased a new stake in Acuren during the third quarter valued at $43,923,000. Cercano Management LLC purchased a new stake in Acuren during the third quarter valued at $38,629,000. Geode Capital Management LLC bought a new position in Acuren in the second quarter valued at about $25,003,000. Finally, Bernzott Capital Advisors purchased a new position in Acuren in the third quarter worth about $9,879,000.
Analyst Upgrades and Downgrades
Several research firms have recently commented on TIC. Jefferies Financial Group reaffirmed a “buy” rating and set a $15.00 price target on shares of Acuren in a research report on Friday, November 14th. Zacks Research upgraded shares of Acuren to a “hold” rating in a research report on Tuesday, December 16th. JPMorgan Chase & Co. initiated coverage on shares of Acuren in a report on Friday, January 9th. They set an “overweight” rating and a $16.00 target price for the company. Finally, UBS Group decreased their price target on shares of Acuren from $15.00 to $11.50 and set a “neutral” rating on the stock in a research report on Friday, November 14th. Two research analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the company. According to data from MarketBeat.com, the stock presently has a consensus rating of “Hold” and a consensus price target of $14.38.
Acuren Price Performance
TIC stock opened at $9.47 on Monday. The company’s fifty day moving average price is $10.27 and its 200-day moving average price is $10.99. Acuren Corp has a one year low of $8.76 and a one year high of $14.94.
Acuren Profile
Acuren Group Inc (NYSEAMERICAN:TIC) is a leading provider of non‐destructive testing (NDT), inspection, engineering and consulting services to the energy, petrochemical, manufacturing and infrastructure sectors. The company employs a range of advanced testing techniques—such as ultrasonic, radiographic, magnetic particle, liquid penetrant, eddy current and acoustic emission—to evaluate the integrity of pressure vessels, pipelines, storage tanks and other critical assets. By combining field inspections with laboratory analysis, Acuren helps clients identify defects, prevent equipment failures and meet regulatory requirements.
In addition to core NDT capabilities, Acuren offers specialty engineering and consulting services including fitness‐for‐service assessments, corrosion under insulation surveys, mechanical integrity programs, failure analysis and field machining.
See Also
- Five stocks we like better than Acuren
- Silver Crossed $100: Is the $500 surge next? (Join us March 4)
- America’s 1776 happening again
- Unlocked: Elon Musk’s Next Big IPO
- Silver paying 20% dividend. Plus 68% share gains
- REVEALED: Something Big Happening Behind White House Doors
Want to see what other hedge funds are holding TIC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Acuren Corp (NYSEAMERICAN:TIC – Free Report).
Receive News & Ratings for Acuren Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Acuren and related companies with MarketBeat.com's FREE daily email newsletter.
